267 related articles for article (PubMed ID: 17083035)
1. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
[TBL] [Abstract][Full Text] [Related]
2. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
Heather Watts D; Mofenson LM
J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
[No Abstract] [Full Text] [Related]
3. The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women.
Dow A; Kayira D; Hudgens MG; Van Rie A; King CC; Ellington S; Chome N; Kourtis A; Turner AN; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
Infect Dis Obstet Gynecol; 2013; 2013():340702. PubMed ID: 24363547
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcomes and risk factors for low birth weight and preterm delivery among HIV-infected pregnant women in Guangxi, China.
Yu L; Li WY; Chen RY; Tang ZR; Pang J; Gui XZ; Meng XN; Zhang FJ
Chin Med J (Engl); 2012 Feb; 125(3):403-9. PubMed ID: 22490393
[TBL] [Abstract][Full Text] [Related]
5. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania.
Fawzi WW; Msamanga GI; Spiegelman D; Urassa EJ; McGrath N; Mwakagile D; Antelman G; Mbise R; Herrera G; Kapiga S; Willett W; Hunter DJ
Lancet; 1998 May; 351(9114):1477-82. PubMed ID: 9605804
[TBL] [Abstract][Full Text] [Related]
6. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
Mulenga V; Ford D; Walker AS; Mwenya D; Mwansa J; Sinyinza F; Lishimpi K; Nunn A; Gillespie S; Zumla A; Chintu C; Gibb DM;
AIDS; 2007 Jan; 21(1):77-84. PubMed ID: 17148971
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda.
Watera C; Todd J; Muwonge R; Whitworth J; Nakiyingi-Miiro J; Brink A; Miiro G; Antvelink L; Kamali A; French N; Mermin J
J Acquir Immune Defic Syndr; 2006 Jul; 42(3):373-8. PubMed ID: 16810124
[TBL] [Abstract][Full Text] [Related]
8. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
Harambat J; Fassinou P; Becquet R; Touré P; Rouet F; Dabis F; Msellati P; Blanche S; Timité-Konan M; Salamon R; Leroy V;
BMC Public Health; 2008 May; 8():169. PubMed ID: 18492259
[TBL] [Abstract][Full Text] [Related]
9. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
Grimwade K; Swingler GH
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
[TBL] [Abstract][Full Text] [Related]
10. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members.
Mermin J; Lule J; Ekwaru JP; Downing R; Hughes P; Bunnell R; Malamba S; Ransom R; Kaharuza F; Coutinho A; Kigozi A; Quick R
AIDS; 2005 Jul; 19(10):1035-42. PubMed ID: 15958834
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.
Pitter C; Kahn JG; Marseille E; Lule JR; McFarland DA; Ekwaru JP; Bunnell R; Coutinho A; Mermin J
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):336-43. PubMed ID: 17327758
[TBL] [Abstract][Full Text] [Related]
12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
13. Increased risks of preterm birth and a low-birth-weight baby in Thai human immunodeficiency virus-positive pregnant women with periodontitis.
Pattrapornnan P; DeRouen TA; Songpaisan Y
J Periodontol; 2012 Nov; 83(11):1372-81. PubMed ID: 22288486
[TBL] [Abstract][Full Text] [Related]
14. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
16. Impact of pregnancy on maternal AIDS.
Kumar RM; Uduman SA; Khurrana AK
J Reprod Med; 1997 Jul; 42(7):429-34. PubMed ID: 9252934
[TBL] [Abstract][Full Text] [Related]
17. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.
Lambert JS; Watts DH; Mofenson L; Stiehm ER; Harris DR; Bethel J; Whitehouse J; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H; van Dyke R; Maupin R; Silio M; Fowler MG
AIDS; 2000 Jul; 14(10):1389-99. PubMed ID: 10930154
[TBL] [Abstract][Full Text] [Related]
19. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
